Grape King Bio Ltd (1707.TW)
TWD 151.0
(0.0%)
TWD 151.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 737.18 Million TWD | 7.09% |
| 2022 | 688.39 Million TWD | -4.29% |
| 2021 | 719.25 Million TWD | 4.32% |
| 2020 | 689.46 Million TWD | 26.17% |
| 2019 | 546.44 Million TWD | -2.91% |
| 2018 | 562.83 Million TWD | 14.38% |
| 2017 | 492.05 Million TWD | 13.12% |
| 2016 | 434.99 Million TWD | 21.01% |
| 2015 | 359.47 Million TWD | 34.0% |
| 2014 | 268.26 Million TWD | 14.08% |
| 2013 | 235.16 Million TWD | 11.34% |
| 2012 | 211.21 Million TWD | 12.87% |
| 2011 | 187.14 Million TWD | -5.57% |
| 2010 | 198.17 Million TWD | 45.08% |
| 2009 | 136.59 Million TWD | 0.41% |
| 2008 | 136.02 Million TWD | 0.52% |
| 2007 | 135.33 Million TWD | -7.57% |
| 2006 | 146.41 Million TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 764.7 Million TWD | 3.73% |
| 2024 Q2 | 814.54 Million TWD | 6.52% |
| 2023 Q1 | 735.05 Million TWD | 6.78% |
| 2023 Q3 | 757.65 Million TWD | 2.62% |
| 2023 Q2 | 738.3 Million TWD | 0.44% |
| 2023 FY | 737.18 Million TWD | 7.09% |
| 2023 Q4 | 737.18 Million TWD | -2.7% |
| 2022 FY | 688.39 Million TWD | -4.29% |
| 2022 Q1 | 705.04 Million TWD | -1.98% |
| 2022 Q4 | 688.39 Million TWD | -5.91% |
| 2022 Q3 | 731.65 Million TWD | 6.49% |
| 2022 Q2 | 687.08 Million TWD | -2.55% |
| 2021 Q1 | 727.18 Million TWD | 5.47% |
| 2021 FY | 719.25 Million TWD | 4.32% |
| 2021 Q3 | 782.72 Million TWD | 4.23% |
| 2021 Q4 | 719.25 Million TWD | -8.11% |
| 2021 Q2 | 750.99 Million TWD | 3.27% |
| 2020 FY | 689.46 Million TWD | 26.17% |
| 2020 Q1 | 595.12 Million TWD | 8.91% |
| 2020 Q2 | 662.88 Million TWD | 11.38% |
| 2020 Q3 | 720.09 Million TWD | 8.63% |
| 2020 Q4 | 689.46 Million TWD | -4.25% |
| 2019 Q1 | 551.59 Million TWD | -2.0% |
| 2019 Q2 | 546.29 Million TWD | -0.96% |
| 2019 Q3 | 583.81 Million TWD | 6.87% |
| 2019 Q4 | 546.44 Million TWD | -6.4% |
| 2019 FY | 546.44 Million TWD | -2.91% |
| 2018 FY | 562.83 Million TWD | 14.38% |
| 2018 Q4 | 562.83 Million TWD | -5.67% |
| 2018 Q3 | 596.67 Million TWD | 14.62% |
| 2018 Q2 | 520.57 Million TWD | 17.54% |
| 2018 Q1 | 442.87 Million TWD | -9.99% |
| 2017 Q1 | 452.22 Million TWD | 3.96% |
| 2017 FY | 492.05 Million TWD | 13.12% |
| 2017 Q4 | 492.05 Million TWD | -6.52% |
| 2017 Q2 | 492.98 Million TWD | 9.01% |
| 2017 Q3 | 526.38 Million TWD | 6.77% |
| 2016 Q1 | 389.38 Million TWD | 8.32% |
| 2016 FY | 434.99 Million TWD | 21.01% |
| 2016 Q3 | 498.23 Million TWD | 7.25% |
| 2016 Q4 | 434.99 Million TWD | -12.69% |
| 2016 Q2 | 464.55 Million TWD | 19.3% |
| 2015 Q3 | 365.46 Million TWD | 12.39% |
| 2015 FY | 359.47 Million TWD | 34.0% |
| 2015 Q4 | 359.47 Million TWD | -1.64% |
| 2015 Q2 | 325.17 Million TWD | 13.94% |
| 2015 Q1 | 285.38 Million TWD | 6.38% |
| 2014 Q4 | 268.26 Million TWD | 9.48% |
| 2014 Q2 | 223.6 Million TWD | -7.12% |
| 2014 Q1 | 240.74 Million TWD | 2.37% |
| 2014 FY | 268.26 Million TWD | 14.08% |
| 2014 Q3 | 245.03 Million TWD | 9.59% |
| 2013 Q4 | 235.16 Million TWD | -1.04% |
| 2013 Q3 | 237.63 Million TWD | 7.48% |
| 2013 Q2 | 221.09 Million TWD | -4.27% |
| 2013 Q1 | 230.95 Million TWD | 9.34% |
| 2013 FY | 235.16 Million TWD | 11.34% |
| 2012 Q1 | 198.17 Million TWD | 5.9% |
| 2012 FY | 211.21 Million TWD | 12.87% |
| 2012 Q2 | 194.42 Million TWD | -1.89% |
| 2012 Q3 | 212.65 Million TWD | 9.38% |
| 2012 Q4 | 211.21 Million TWD | -0.68% |
| 2011 Q2 | 181.28 Million TWD | -1.45% |
| 2011 FY | 187.14 Million TWD | -5.57% |
| 2011 Q1 | 183.95 Million TWD | -7.17% |
| 2011 Q4 | 187.14 Million TWD | -2.57% |
| 2011 Q3 | 192.07 Million TWD | 5.95% |
| 2010 FY | 198.17 Million TWD | 45.08% |
| 2010 Q4 | 198.17 Million TWD | 0.0% |
| 2009 FY | 136.59 Million TWD | 0.41% |
| 2008 FY | 136.02 Million TWD | 0.52% |
| 2007 FY | 135.33 Million TWD | -7.57% |
| 2006 FY | 146.41 Million TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Standard Chem & Pharm CO., LTD. | 1.61 Billion TWD | 54.353% |
| Maywufa Company Ltd. | 257.91 Million TWD | -185.83% |
| ScinoPharm Taiwan, Ltd. | 1.51 Billion TWD | 51.229% |
| Lotus Pharmaceutical Co., Ltd. | 3.77 Billion TWD | 80.474% |
| LIWANLI Innovation Co., Ltd. | 60.81 Million TWD | -1112.098% |
| YungShin Global Holding Corporation | 2.77 Billion TWD | 73.416% |
| PhytoHealth Corporation | 163.09 Million TWD | -352.012% |
| SCI Pharmtech, Inc. | 529.53 Million TWD | -39.214% |
| Formosa Laboratories, Inc. | 1.59 Billion TWD | 53.853% |
| PharmaEssentia Corporation | 1.45 Billion TWD | 49.461% |
| Bora Pharmaceuticals Co., LTD. | 2.15 Billion TWD | 65.81% |